Opinion|Videos|January 28, 2025
Optimizing Care Models for Bispecific Antibodies: Strategies for Cost-Effective Delivery
Author(s)Jeffrey V. Matous, MD
Jeffrey V. Matous, MD, discusses how best practices in transitioning care between academic and community centers can enhance patient outcomes when receiving bispecific antibodies, and the critical role managed care organizations play in facilitating cost-effective integration of these therapies into community settings through optimized partnerships.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What best practices can improve transitions of care between academic and community centers for patients receiving bispecific antibodies?
- What role do managed care organizations play in facilitating the integration of bispecific antibody therapies into community settings, and how can partnerships be optimized to ensure cost-effective care delivery?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
4
New Dermatologic Therapies Make Waves at Maui Derm 2026
5
